Acellular Pertussis Completed Phase 4 Trials for Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00611559Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old ChildrenPrevention